COVID-19 Vaccine Information

In order to collect an accurate count of who still needs the vaccine, please let LSU know if you've already been vaccinated by completing the survey below.

I've Been Vaccinated

Johnson & Johnson Vaccine Update

For those who have received the Johnson & Johnson vaccine, whether at LSU or elsewhere, and have concerns about the CDC and FDA pausing the use of that vaccine, below is some information that you may find helpful.

  • The CDC has said the condition it is investigating in some vaccine recipients appears to be “extremely rare.” As of April 12, there were 6 cases reported out of more than 6.8 million doses of the Johnson & Johnson vaccine.
  • The pause in giving the vaccine is to allow time for the CDC and FDA to look into these cases and determine if they are connected to the vaccine.  
  • If you have concerns, or are experiencing any abnormal symptoms, you should contact your health care provider, or students may contact the Student Health Center at 225-578-6716.  
  • According to the CDC, recipients of the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within 3 weeks after vaccination should contact their health care provider. 
  • This situation only pertains to the Johnson & Johnson vaccine. There are no reported concerns with the Moderna or Pfizer vaccines.
  • Health authorities still recommend being vaccinated, as the risk of getting COVID-19 is far greater than the risk of any vaccine-related concerns.

Frequently Asked Questions (FAQs)

Eligibility for the COVID-19 vaccine is determined by the Louisiana Department of Health. To view who is currently eligible, please visit the LDH website.

LSU will follow Louisiana Department of Health's tiers for distribution. Priority will not be given outside of these tiers. 

No. LSU only plans to vaccinate faculty, staff, and students. 

If you are not available to receive the second dose of the vaccine at the given time period, we ask that you notify the LSU EOC immediately. The CDC recommends that you receive the second dose as soon as possible if you miss the date that your second dose should be administered. 

Have concerns about the coronavirus vaccine? Here are the facts.

For those who have received the Johnson & Johnson vaccine, whether at LSU or elsewhere, and have concerns about the CDC and FDA pausing the use of that vaccine, below is some information that you may find helpful.

  • The CDC has said the condition it is investigating in some vaccine recipients appears to be “extremely rare.” As of April 12, there were 6 cases reported out of more than 6.8 million doses of the Johnson & Johnson vaccine.
  • The pause in giving the vaccine is to allow time for the CDC and FDA to look into these cases and determine if they are connected to the vaccine.  
  • If you have concerns, or are experiencing any abnormal symptoms, you should contact your health care provider, or students may contact the Student Health Center at 225-578-6716.  
  • According to the CDC, recipients of the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within 3 weeks after vaccination should contact their health care provider. 
  • This situation only pertains to the Johnson & Johnson vaccine. There are no reported concerns with the Moderna or Pfizer vaccines.
  • Health authorities still recommend being vaccinated, as the risk of getting COVID-19 is far greater than the risk of any vaccine-related concerns.

No! The vaccines work by teaching your immune system how to respond and protect you from exposure to the coronavirus.

Each vaccine brand has proven to be effective at preventing serious illness and hospitalization from COVID-19. The Pfizer and Moderna vaccines are more than 90 percent effective at preventing all infections of COVID-19, and the Johnson & Johnson vaccine is 72 percent effective—far surpassing the minimum efficacy set by the FDA of 50 percent.

COVID-19 vaccines don’t interact with your DNA. The Pfizer and Moderna vaccines use messenger RNA (mRNA), a technology that has existed for decades but is groundbreaking in the COVID-19 vaccine. The Johnson & Johnson vaccine uses more traditional virus-based technology.

The Johnson & Johnson vaccine uses a disabled adenovirus unrelated to the coronavirus to deliver protection instructions. This disabled adenovirus can’t replicate in your body and won’t give you a viral infection. 

mRNA vaccines teach our cells how to make a protein that triggers your immune system.

Despite false or misleading claims, no steps were skipped in the vaccine’s development. More than 100,000 people participated in the various vaccine clinical trials and underwent rigorous observation during and after vaccination. Many scientists believe the pandemic has actually ushered in a new era of vaccine research. The vaccine’s rapid development was possible because of previous research about other coronaviruses, a global collaboration between scientists, funding from the government and private sector, and the breakthrough in mRNA technology.

Handwashing, masks, and social distancing in combination with the vaccine are still necessary to overcome COVID-19 and return our community back to normal sooner, since it’s still unclear how much vaccination prevents transmission to others who aren’t vaccinated.

Even people who have already had COVID-19 can receive the vaccine to protect against reinfection.

While the vaccine isn’t ineffective against the variants, it is less effective; however, it still provides some worthwhile protection against them.

As your body builds protection after receiving the vaccine, you may experience common side effects including pain or swelling at the injection side, fever, chills, tiredness, and headache. If you experience any side effects that cause concern, please consult with a medical professional.